Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma
Coleman J Bryan1, Mark N Prichard, Shannon Daily
1Division of Pediatric Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. Coleman.Bryan@med.navy.mil
Abstract:
A 21-month-old girl with neuroblastoma developed chronic verrucous Oka strain varicella-zoster infection during chemotherapy. Virus isolated from the patient demonstrated high-level acyclovir resistance, and its thymidine kinase had no in vitro enzymatic activity. After foscarnet therapy, she underwent stem cell transplantation without varicella reactivation. This is only the second reported case of resistant varicella zoster virus caused by Oka strain virus.
Related Concept Videos
Chickenpox
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Genital Herpes
Treatment Resistent Cancers
Treatment Resistant Cancers

